Capital Flow Monitor · Sponsors · CIK 2040270
BBK Ventures Fund I, LP
3889 MAPLE AVENUE, DALLAS, TX, 75219 · 619-410-3334
Pooled Investment Fund / Other Investment Fund · Limited Partnership· inc. DELAWARE true 2024
Fit score
—
Offering
$100.0M
Sold
$87.5M
% sold
87.5%
Investors
57
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-24 | D/A ·current | 506(b) | $100.0M | $87.5M | 87.5% | 57 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Paul N Breedlove — Executive Officer, DALLAS, TX
- Max Korenvaes — Executive Officer, DALLAS, TX
-
Tyler Brous — Executive Officer, DALLAS, TX
4 other raises
- Kayak Therapeutics, Inc. $25.0M of $30.0M · 83.3%
- BBK Cesium I SPV, LLC $7.1M of $7.1M · 100.0%
- LCP Quantum Partners VI, LLC $6.4M of $6.4M · 100.0%
- ColdQuanta, Inc. $7.5M of $7.5M · 100.0%
- - BBK Ventures GP, LLC — Executive Officer, DALLAS, TX
- - BBK Management Co., LLC — Promoter, Dallas, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.